Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 21, 2006

View Archived Issues

Bryostatin 1 provides protection against ischemia/reperfusion injury

Orally available novel nucleotide is active against drug-resistant HIV-1 mutants

Updated profile of ARD-353, a cardioprotective nonpeptide delta opioid receptor agonist

Tadalafil improves neurological function in a preclinical stroke model

Initial preclinical data for ReN-004 stem cell lines for Parkinson's disease

Three registrational phase III trials of Erbitux complete enrollment

New phase III trial studies Nexavar in NSCLC

17beta-Estradiol targets STAT3 to provide neuroprotection following stroke

Dana-Farber Cancer Institute to study CTCE-9908 for brain cancer

BioInvent reassigns rights to develop osteoarthritis drugs to Cartela

CFFT to continue support for Copernicus' gene therapy for cystic fibrosis

New studies suggest Ampligen and Alferon may protect against avian flu

NNZ-4921 shows promise in rat peripheral neuropathy model

Results of studies investigating AAGP effect on cellular growth and function

Orphan drug designation for Coramsine for melanoma

Targeting gamma-secretase provides neuroprotection in preclinical stroke

Novel compounds with possible utility in the treatment of cancer revealed

Preclinical and clinical data on JTK-303/GS-9137 disclosed

New therapeutic agents for acne disclosed in recent Galderma patent

Rho kinase inhibitors prepared and tested at GlaxoSmithKline

CD38-derived peptide shows potent anti-HIV-1 activity in vitro

New HIV protease inhibitor shows promise for multidrug-resistant HIV infection

Pilot bioavailability testing of CDT extended release ondansetron tablets

Vusion approved for treatment of diaper dermatitis complicated by candidiasis

Hycamtin sNDA accepted for priority review

Rimonabant receives approvable, nonapprovable letters

FDA approval for new oral contraceptive Loestrin 24 Fe

CE Mark for CoStar paclitaxel-eluting stent

Alvesco approved in Europe for mild to severe persistent asthma in adolescents

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...